Use of metformin and risk of breast and colorectal cancer

Diabetes has been associated with increased risk of cancer, including breast cancer and colorectal cancer. Metformin, an oral hypoglycemic drug, but not other anti-diabetic drugs, has been associated with reduced risk of breast and of colon cancers in some, but not in other, studies.

Source: Diabetes Research and Clinical Practice - May 20, 2020 Category: Endocrinology Authors: Gad Rennert, Hedy S. Rennert, Naomi Gronich, Mila Pinchev, Stephen B Gruber Source Type: research